HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Panagiotis Theofilis Selected Research

Glucose (Dextrose)

12/2023The Role of Ranolazine in Heart Failure-Current Concepts.
10/2022Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations.
10/2022The impact of SGLT2 inhibitors on inflammation: A systematic review and meta-analysis of studies in rodents.
6/2022Pleiotropic effects of SGLT2 inhibitors and heart failure outcomes.
1/2022The Role of Melatonin in Chronic Kidney Disease and Its Associated Risk Factors: A New Tool in Our Arsenal?
1/2022The impact of SGLT2 inhibition on imaging markers of cardiac function: A systematic review and meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Panagiotis Theofilis Research Topics

Disease

17Inflammation (Inflammations)
05/2024 - 10/2021
12Atherosclerosis
08/2023 - 07/2021
12Coronary Artery Disease (Coronary Atherosclerosis)
07/2023 - 01/2021
10Heart Failure
04/2024 - 01/2019
9Cardiovascular Diseases (Cardiovascular Disease)
07/2023 - 01/2021
7Acute Coronary Syndrome
04/2024 - 01/2023
7COVID-19
03/2023 - 06/2021
5Thrombosis (Thrombus)
09/2023 - 01/2020
4Atrial Fibrillation
04/2024 - 01/2019
4Diabetes Mellitus
02/2023 - 01/2020
4Kidney Diseases (Kidney Disease)
01/2023 - 01/2022
4Hemorrhage
09/2022 - 01/2020
3Cardio-Renal Syndrome
02/2024 - 01/2023
3Fibrosis (Cirrhosis)
01/2024 - 01/2019
3Carotid Artery Diseases
11/2023 - 11/2021
3Heart Diseases (Heart Disease)
06/2023 - 06/2021
3Ischemia
06/2023 - 12/2021
3Atherosclerotic Plaque (Atheroma)
01/2023 - 01/2022
3Hypertension (High Blood Pressure)
01/2023 - 01/2022
3Chronic Kidney Failure (Chronic Renal Failure)
01/2023 - 01/2021
3Peripheral Arterial Disease
09/2022 - 12/2021
3Thromboembolism
09/2022 - 01/2022
2Dyslipidemias (Dyslipidemia)
04/2024 - 01/2021
2Pericarditis
02/2024 - 10/2023
2Hyperglycemia
11/2023 - 01/2022
2Insulin Resistance
01/2023 - 01/2022
2Type 2 Diabetes Mellitus (MODY)
01/2023 - 06/2022
2Obesity
01/2023 - 10/2022
2Cardiac Arrhythmias (Arrythmia)
09/2022 - 01/2022
2Disease Progression
01/2022 - 01/2022
2Chronic Renal Insufficiency
01/2022 - 01/2022
2Acute Kidney Injury (Acute Renal Failure)
01/2022 - 12/2021
2Myocardial Infarction
01/2020 - 01/2020
1Hypotension (Low Blood Pressure)
04/2024
1Hyperkalemia
04/2024
1Genetic Predisposition to Disease (Genetic Predisposition)
04/2024
1Starvation
12/2023
1Hypoglycemia (Reactive Hypoglycemia)
11/2023

Drug/Important Bio-Agent (IBA)

22Biomarkers (Surrogate Marker)IBA
05/2024 - 01/2019
7Interleukin-6 (Interleukin 6)IBA
05/2024 - 01/2019
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2024 - 01/2020
7CytokinesIBA
07/2023 - 01/2020
6MicroRNAs (MicroRNA)IBA
04/2024 - 01/2021
6Glucose (Dextrose)FDA LinkGeneric
12/2023 - 01/2022
6SodiumIBA
12/2023 - 01/2022
5Lipoprotein(a)IBA
04/2024 - 01/2021
5Interleukin-1 (Interleukin 1)IBA
02/2024 - 01/2020
4Natriuretic PeptidesIBA
12/2023 - 01/2022
4TroponinIBA
09/2023 - 01/2022
4Sodium-Glucose Transporter 2 InhibitorsIBA
02/2023 - 06/2022
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2024 - 01/2023
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
07/2023 - 01/2021
3AnticoagulantsIBA
01/2023 - 01/2022
3Indicators and Reagents (Reagents)IBA
01/2023 - 01/2022
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
05/2024 - 09/2022
2SymportersIBA
12/2023 - 10/2022
2InflammasomesIBA
08/2023 - 06/2023
2InterleukinsIBA
07/2023 - 12/2022
2InterferonsIBA
07/2023 - 12/2022
2ChemokinesIBA
07/2023 - 12/2022
2Interleukin-18 (Interleukin 18)IBA
06/2023 - 01/2022
2trimethyloxamine (trimethylamine N-oxide)IBA
02/2023 - 12/2022
2Lipoproteins (Lipoprotein)IBA
01/2023 - 12/2022
2tocilizumab (atlizumab)FDA Link
12/2022 - 12/2021
2Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
12/2022 - 12/2021
2Hypoglycemic Agents (Hypoglycemics)IBA
10/2022 - 06/2022
2Toll-Like Receptors (Toll-Like Receptor)IBA
01/2022 - 10/2021
2Cell Adhesion MoleculesIBA
01/2022 - 01/2020
2Immunologic Factors (Immunomodulators)IBA
12/2021 - 06/2021
2Anti-Inflammatory Agents (Anti-Inflammatories)IBA
12/2021 - 06/2021
1OsteopontinIBA
05/2024
1Angiopoietin-Like Protein 3IBA
04/2024
1oxidized low density lipoproteinIBA
04/2024
18- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA
04/2024
1finerenoneIBA
04/2024
1LDL CholesterolIBA
04/2024
1Mineralocorticoid Receptor AntagonistsIBA
04/2024
1Peptides (Polypeptides)IBA
02/2024
1DiureticsIBA
02/2024
1Azathioprine (Imuran)FDA LinkGeneric
02/2024
1Immunosuppressive Agents (Immunosuppressants)IBA
02/2024
1Immunoglobulins (Immunoglobulin)IBA
02/2024
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
02/2024
1GlucocorticoidsIBA
02/2024
1ColchicineFDA LinkGeneric
02/2024
1GadoliniumIBA
01/2024
1RanolazineFDA Link
12/2023
1Fatty Acids (Saturated Fatty Acids)IBA
12/2023
1Calcium-Transporting ATPases (Ca2+ ATPase)IBA
12/2023
1Sodium-Calcium ExchangerIBA
12/2023
1Ion Channels (Ion Channel)IBA
12/2023
1Insulin (Novolin)FDA Link
11/2023
1Drinking WaterIBA
11/2023

Therapy/Procedure

12Therapeutics
12/2023 - 01/2020
3Percutaneous Coronary Intervention
11/2023 - 01/2021
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
11/2023 - 01/2023
2Drug Therapy (Chemotherapy)
10/2023 - 01/2023
2Secondary Prevention
01/2023 - 01/2020
2Renal Replacement Therapy (Therapies, Renal Replacement)
01/2022 - 01/2021
1Precision Medicine
04/2024